High levels of exposure to phthalates have been associated with an increased risk for adverse male fetal reproductive development. Although animal studies have consistently demonstrated reproductive health effects, additional human epidemiological studies are needed to fully understand the potential harm to humans. Recent findings reported for humans have demonstrated endocrine-disrupting action similar to that associated with phthalate exposures in animals. As a result, phthalate exposure is an emerging public health concern that warrants further review. This article explores the state of the science on phthalate exposure, reviews the literature, and provides recommendations occupational health nurses can use to optimize the health of susceptible populations.
References
1.
BetitP., & CraigN. (2009). Extracorporeal membrane oxygenation for neonatal respiratory failure. Respiratory Care, 54(9), 1244–1251.
2.
BlountB. C.SilvaM. J.CaudillS. P.NeedhamL. L.PirkleJ. L.SampsonE. J. (2000). Levels of seven urinary phthalate metabolites in a human reference population. Environmental Health Perspectives, 108(10), 979–982.
3.
CarruthersC. M., & FosterP. M. (2005). Critical window of male reproductive tract development in rats following gestational exposure to di-n-butyl phthalate. Birth Defects Research. Part B, Developmental and Reproductive Toxicology, 74(3), 277–285.
4.
Centers for Disease Control and Prevention. (2005). Third national report on human exposure to environmental chemicals. Retrieved from www.cdc.gov/exposurereport
5.
DutyS. M.AckermanR. M.CalafatA. M., & HauserR. (2005). Personal care product use predicts urinary concentrations of some phthalate monoesters. Environmental Health Perspectives, 113(11), 1530–1535.
6.
Environmental Working Group. (2000). Researchers warn consumers about hazardous ingredient in nail polish: Growing scientific concern about dibutyl phthalate (DBP), reproductive age women and links to birth defects. Retrieved from www.ewg.org/node/26957
7.
Environmental Working Group. (2006). Industry spin vs. fact. Retrieved from www.ewg.org/node/8174
8.
FosterP. M. (2006). Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. International Journal of Andrology, 29(1), 140–147; discussion 181–185.
9.
FosterP. M.CattleyR. C., & MyIchreestE. (2000). Effects of di-n-butyl phthalate (DBP) on male reproductive development in the rat: Implications for human risk assessment. Food and Chemical Toxicology, 38(1 Suppl.), S97–S99.
10.
GrayL. E.Jr.WilsonV. S.StokerT.LambrightC.FurrJ.NoriegaN. (2006). Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. International Journal of Andrology, 29(1), 96–104; discussion 105–108.
11.
GreenR.HauserR.CalafatA. M.WueveJ.SchettlerT.RingerS. (2005). Use of di(2-ethylhexyl) phthalate containing medical products and urinary levels of mono (2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environmental Health Perspectives, 113, 1222–1225.
12.
HillmanL. S.GoodwinS. L., & ShermanW. R. (1975). Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. The New England Journal of Medicine, 292(8), 381–386.
13.
KooH. J., & LeeB. M. (2004). Estimated exposure to phthalates in cosmetics and risk assessment. Journal of Toxicology and Environmental Health. Part A, 67(23–24), 1901–1914.
14.
KwapniewskiR.KozaczkaS.HauserR.SilvaM. J.CalafatA. M., & DutyS. M. (2008). Occupational exposure to dibutyl phthalate among manicurists. Journal of Occupational and Environmental Medicine, 50(6), 705–711.
15.
LatiniG.De FeliceC.PrestaG.Del VecchioA.ParisI.RuggieriF. (2003). In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environmental Health Perspectives, 111(14), 1783–1785.
16.
LoffS.KabsF.WittK.SartorisJ.MandlB.NiessenK. H. (2000). Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. Journal of Pediatric Surgery, 35(12), 1775–1781.
17.
Lovekamp-SwanT., & DavisB. J. (2003). Mechanisms of phthalate ester toxicity in the female reproductive system. Environmental Health Perspectives, 111(2), 139–145.
18.
MainK. M.MortensenG. K.KalevaM. M.BoisenK. A.DamgaardI. N.ChellakootyM. (2006). Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environmental Health Perspectives, 114(2), 270–276.
19.
MarseeK.WoodruffT. J.AxelradD. A.CalafatA. M., & SwanS. H. (2006). Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environmental Health Perspectives, 114(6), 805–809.
20.
National Research Council. (1999). Hormonally active agents in the environment. Washington, DC: National Academy Press.
21.
PakV. M., & McCauleyL. A. (2007). Risks of phthalate exposure among the general population: Implications for occupational health nurses. AAOHN Journal, 55(1), 12–17.
22.
PakV. M.NailonR. E., & McCauleyL. A. (2007). Controversy: Neonatal exposure to plasticizers in the NICU. MCN: The American Journal of Maternal Child Nursing, 32(4), 244–249.
23.
PanG.HanaokaT.YoshimuraM.ZhangS.WangP.TsukinoH. (2006). Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): A cross-sectional study in China. Environmental Health Perspectives, 114(11), 1643–1648.
24.
PlonaitS. L.NauH.MaierR. F.WittfohtW., & ObladenM. (1993). Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2–ethylhexanoic acid following exchange transfusion with Polyvinylchloride catheters. Transfusion, 33(7), 598–605.
25.
Rais-BahramiK.NunezS.RevenisM. E.LubanN. L., & ShortB. L. (2004). Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environmental Health Perspectives, 112(13), 1339–1340.
26.
SathyanarayanaS.KarrC. J.LozanoP.BrownE.CalafatA. M.LiuF. (2008). Baby care products: Possible sources of infant phthalate exposure. Pediatrics, 121(2), e260–e268.
27.
Shea, K. M., & American Academy of Pediatrics Committee on Environmental Health. (2003). Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics, 111(6 Pt. 1), 1467–1474.
28.
SilvaM. J.BarrD. B.ReidyJ. A.MalekN. A.HodgeC. C.CaudillS. P. (2004). Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999–2000. Environmental Health Perspectives, 112(3), 331–338.
29.
SjobergP. O.BondessonU. G.SedinE. G., & GustafssonJ. P. (1985). Exposure of newborn infants to plasticizers: Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion. Transfusion, 25(5), 424–428.
30.
SwanS. H.MainK. M.LiuF.StewartS. L.KruseR. L.CalafatA. M. (2005). Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives, 113(8), 1056–1061.
U.S. Food and Drug Administration. (2002). PVC devices containing the plasticizer DEHP. Retrieved from www.fda.gov/cdrh/safety/dehp.html
33.
WittassekM., & AngererJ. (2008). Phthalates: Metabolism and exposure. International Journal of Andrology, 31(2), 131–138.
34.
WormuthM.ScheringerM.VollenweiderM., & HungerbuhlerK. (2006). What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?Risk Analysis, 26(3), 803–824.
